Skip to content

Nanoscope Cost Analysis Study

Randomized Study Evaluating Cost of Arthrex Nano Arthroscopy Products in Arthroscopic Knee Meniscectomy Versus Conventional Arthroscopy

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06603740
Enrollment
10
Registered
2024-09-19
Start date
2024-11-30
Completion date
2025-07-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniscal Tear

Brief summary

The study is a pilot study designed to generate preliminary data regarding the cost of partial meniscectomy using NanoScope versus conventional arthroscopy in a traditional operating room (OR) setting

Interventions

DEVICEArthrex Nanoscope

Arthrex's all-in-one disposable, 2 mm, chip-on-tip camera system now allows surgeons to miniaturize their treatment solutions

DEVICEConventional Arthroscopy without Arthrex Nanoscope

partial meniscectomy using conventional arthroscopy

Sponsors

Arthrex, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. Subject requires simple partial posterior or mid-body meniscectomy. 2. Subject is 18 - 60 years of age. 3. Subject body mass index (BMI) is 35 or lower (BMI ≤ 35). 4. Subject signed informed consent and is willing and able to comply with all study requirements and follow-up visits. 5. Confirmed meniscal injury by physical exam as per standard of care. 6. Normal mechanical alignment; \< 5° varus and \< 7° valgus, of the affected knee by clinical assessment or X-Rays as per standard of care

Exclusion criteria

1. Subject requires complex repair or anterior meniscectomy. 2. Subject has a concomitant chondral lesion of the ipsilateral knee in addition to meniscal tear. 3. Current bilateral knee injury. 4. Insufficient quantity or quality of bone. 5. Blood supply limitations and previous infections which may retard healing. 6. Congenital ligamentous hypermobility defined by Beighton score 4 or 5. 7. Locked knee or haemarthrosis. 8. Subjects that are skeletally immature. 9. Advanced Osteoarthritis; Kellgren Lawrence ≥ 2 10. Fracture of the lower extremities within 6 months prior to screening. 11. Previous surgery on the affected knee within 12 months prior to screening. 12. Sensitivity to silicone, polyester, nylon, FD&C Blue No. 2 dye and beeswax. 13. Other concomitant disease that would interfere with study outcomes. 14. Subject is included in a vulnerable population (child, prisoner, etc). 15. Conditions that tend to limit the patient's ability or willingness to restrict activities, follow directions, or perform online subject assessments during the healing period. 16. Subject is requesting or receiving Worker's compensation related to the knee injury. -

Design outcomes

Primary

MeasureTime frameDescription
Cost Comparison (TDBC)Operative VisitCost comparison using the time-drive activity-based costing (TDABC) study design between NanoScope versus conventional arthroscopy for partial meniscectomy in a traditional OR setting.

Secondary

MeasureTime frameDescription
International Knee Documentation Committee (IKDC) ScorePre Operative, 2 weeks and 6 weeks post opThe IKDC Questionnaire is a subjective scale that provides patients with an overall function score. The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. The symptoms subscale helps to evaluate things such as pain, stiffness, swelling and giving-way of the knee. The questions prompt an answer 0-10. The total score is interpreted as a measure of function with higher scores representing higher levels of function.
Visual Analogue Scale (VAS)Pre Operative, 2 weeks and 6 weeks post opThe visual analog scale for pain is a straight line with one end meaning no pain and the other end meaning the worst pain imaginable. A patient marks a point on the line that matches the amount of pain he or she feels.v

Other

MeasureTime frameDescription
Knee Injury and Osteoarthritis outcome Score (KOOS)Pre Operative, 2 weeks and 6 weeks post opKOOS is a five-subscale patient-reported instrument intended for use from the time of knee injury to the development of osteoarthritis. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures
PROMIS Physical Function 13a scalepreop, 2 weeks post op, and 6 weeks post op
PROMIS Pain Interference 6a scalepreop, 2 weeks post op, and 6 weeks post op
PROMIS Pain Intensity 3a scalepreop, 2 weeks post op, and 6 weeks post op

Countries

United States

Contacts

Primary ContactCarolie I Caraci, BA
caroline.caraci@arthrex.com18009337001

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026